Return to study ST001074 main page
MB Sample ID: SA072470
Local Sample ID: | ATQ-20170207 |
Subject ID: | SU001118 |
Subject Type: | Cultured cells |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Genotype Strain: | 3D7 |
Cell Counts: | 1x10^8 per technical replicate |
Species Group: | Plasmodium falciparum |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR001132 |
Treatment Summary: | Infected Red Blood cells were exposed to Antimalarial Compounds, associated with sample names |
Treatment Protocol Filename: | Metabolite_Extraction_for_LCMS_2017_Llinas.pdf |
Treatment: | Drug Treatment |
Treatment Compound: | MMV1432165, MMV1451822, MMV1068987, MMV1490405, MMV1490397, MMV1449124, MMV1432711, MMV1454442, MMV1010248, MMV1319550, MMV1427995, MMV1431916, MMV011772 |
Treatment Route: | Addition to media |
Treatment Dose: | 10xIC50 |
Treatment Dosevolume: | 10xIC50 |
Treatment Doseduration: | 2.5 hours |
Treatment Vehicle: | Stocks kept in either DMSO or Water |
Cell Storage: | Temperature/Gas Mixture controlled incubator |
Cell Growth Container: | 6-well plate |
Cell Growth Config: | 5 mL per well, each with 1x10^8 cells |
Cell Media: | RPMI 1640 w/ Albumax, Gentamycin, Hypoxanthine, HEPES, Sodium Bicarbonate |
Cell Harvesting: | PBS Wash followed by 90% methanol extraction |